Leo Ehrlich comments on Cellceutix Corporation's breakthroughs with their ground-breaking compound KM-391 for the treatment of autism.
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Blog Archive
-
▼
2010
(13)
-
▼
March
(11)
- Cellceutix CFO, Leo Ehrlich, on KM-391
- Microcap Pipe Dreams or Previews in Reality?
- Cellceutix Corporation: Breaking Down the Autism ...
- Consorteum Holdings, Inc (OTCBB: CSRH)
- CPF - Central Pacific Financial - Another Winner!
- Eternal Image Letter to Shareholders
- ETNL Names President of Upcoming Ancillary Division
- CEO of Eternal Image BUYS shares of company
- Eternal Image Inc. (ETNL) Annotated Video Chart
- OTC Showcase Newsletter Vol. 1 Released - ETNL
- Website open for business
-
▼
March
(11)
No comments:
Post a Comment